Phase 2 Trial Testing H.P. Acthar Gel for ALS Enrolls Half of Patients, Still Recruiting
A Phase 2b clinical trial assessing the efficacy and safety of H.P. Acthar Gel, an experimental injectable therapy for…
Articles by Patricia Inácio, PhD
$2.88M Awarded to Research on How ALS Affects Organs Beyond the Central Nervous System
Scientist Jingsong Zhou, PhD, has received a $2.88-million grant from the National Institutes of Health (NIH) to study…
Alabama Power Foundation Funds Research into New Therapies for ALS
Researchers doing early-stage investigation into potential new ways to halt neuron death seen in amyotrophic lateral sclerosis (ALS) have received…
Restoring Levels of Membralin Protein May Extend Survival in ALS, Mouse Study Suggests
Low levels of membralin protein in the brain cells that support and protect neurons lead to the accumulation of the…
Smartphones May Help Remotely Evaluate Key Clinical Data of ALS, Study Suggests
Using a smartphone to collect amyotrophic lateral sclerosis (ALS) patients’ self-reported scores in the ALS-specific functional rating scale…
Certain Cholesterol-Lowering Statins May Decrease Risk of ALS, Large Medicare-based Study Suggests
Use of statins, the blood cholesterol-lowering medications, for more than a year was linked to a lower risk of developing…
Transplant of Human Neural Stem Cells into ALS Patients Found Safe in Phase 1 Trial
Injection of human neural stem cells into the spinal cord of people with amyotrophic lateral sclerosis (ALS) was found…
Phase 3 Trial Results of Tirasemtiv Show Potential of Similar Therapies for ALS, Researchers Say
People with amyotrophic lateral sclerosis (ALS) who tolerated higher doses of tirasemtiv showed a trend toward slower decline in breathing muscle…
ALS Association Offering New Scholarship Program for Students Affected by ALS
The ALS Association has launched a financial aid program, called The Jane Calmes ALS Scholarship Fund, to help students whose…
Changing TDP-43’s Structure Can Halt Neurodegeneration in ALS and FTD, Study Finds
Accumulation of TDP-43 protein is known to drive neurodegeneration associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Now, researchers…